Προκήρυξη:
Institute of Physiology of the Czech Academy of Sciences (IPHYS), the leading research institution in the field of normal and pathological physiology and biomedical research in the Czech Republic is looking for PhD candidates in the field of neuroscience, metabolism, signal transduction and protein biochemistry. PhD students are employees of the IPHYS enjoying a flat-rate university stipend and up to full-time salary and benefits. PhD studies at the IPHYS start in October 2018 and their main features include:
- Research in the fields of neuroscience, cardiovascular physiology and metabolism
- Experiments conducted at molecular to systemic (whole-organism) level
- Close collaboration with leading clinical institutions
- Modern campus with on-site accommodation for international students, and sports facilities
PhD positions are available in the Departments of:
- Molecular Neurobiology- one available position
- Analysis of Biologically Important Compounds – two available positions
- Cellular and Molecular Neuroendocrinology – one position
- Structural Biology of Signaling Proteins – one available position
- Neurochemistry- three available positions
- Membrane Transport- one available position
- Functional Morphology- one available position
- Cellular Neurophysiology- two available positions
- Bioenergetics- three available positions
The highly motivated and skilled PhD candidates are encouraged to get more information on the website of IPHYS and apply through a web portal also located there.
The candidates will be notified by the end of April 2018 about the outcome of the selection process and will receive detailed information about the next steps necessary to start their PhD studies.
DESIRED SKILLS AND EXPERIENCE
Applicants must hold or anticipate to receive a Master’s degree or equivalent in biology, biochemistry, physiology, medicine or other relevant fields before the start of the PhD program in October 2018.
ABOUT THE EMPLOYER
Institute of Physiology of the Czech Academy of Sciences (IPHYS) is a leading research institution in the field of normal and pathological physiology, found in Prague, Czech Republic. With its research focused mainly on neuroscience, metabolism and cardiovascular physiology, IPHYS is paving the way to novel diagnostic and therapeutic procedures required to tackle human medical conditions. These chiefly include stroke, ischemic heart disease, diabetes, inherited metabolic disorders, neurodevelopmental and neurodegenerative diseases such as Alzheimer’s or epilepsy.
More information about the IPHYS, its research and its PhD program are present at the institute’s webpage: http://www.fgu.cas.cz/en/.